TYSHEENA JONES: Open Payments
NPI 1427590538 · VA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 37 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $960
Food & beverage: $960
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $277 |
| Sumitomo Pharma America, Inc. | 7 | $181 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $122 |
| Merck Sharp & Dohme LLC | 3 | $71 |
| ACCORD HEALTHCARE, INC. | 3 | $61 |
| Endo USA, Inc. | 3 | $60 |
| IMMUNITYBIO, INC. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $39 |
| UROGEN PHARMA, INC. | 1 | $19 |
Products named: GEMTESA, ERLEADA, JOURNAVX, RYBREVANT, KEYTRUDA, Camcevi, AVEED, ANKTIVA.
Industry payments across VA — which companies pay providers there.
